Tuccinardi T - Search Results

1

Effect of Cooking Techniques on the in vitro Protein Digestibility, Fatty Acid Profile, and Oxidative Status of Mealworms (Tenebrio molitor).

Mancini S, Mattioli S, Paolucci S, Fratini F, Dal Bosco A, Tuccinardi T, Paci G. Mancini S, et al. Among authors: tuccinardi t. Front Vet Sci. 2021 Jun 4;8:675572. doi: 10.3389/fvets.2021.675572. eCollection 2021. Front Vet Sci. 2021. PMID: 34150894 Free PMC article.

2

Former Foodstuff Products in Tenebrio Molitor Rearing: Effects on Growth, Chemical Composition, Microbiological Load, and Antioxidant Status.

Mancini S, Fratini F, Turchi B, Mattioli S, Dal Bosco A, Tuccinardi T, Nozic S, Paci G. Mancini S, et al. Among authors: tuccinardi t. Animals (Basel). 2019 Jul 25;9(8):484. doi: 10.3390/ani9080484. Animals (Basel). 2019. PMID: 31349633 Free PMC article.

3

VenomPred 2.0: A Novel In Silico Platform for an Extended and Human Interpretable Toxicological Profiling of Small Molecules.

Di Stefano M, Galati S, Piazza L, Granchi C, Mancini S, Fratini F, Macchia M, Poli G, Tuccinardi T. Di Stefano M, et al. Among authors: tuccinardi t. J Chem Inf Model. 2024 Apr 8;64(7):2275-2289. doi: 10.1021/acs.jcim.3c00692. Epub 2023 Sep 7. J Chem Inf Model. 2024. PMID: 37676238 Free PMC article.

4

Editorial: Peptidyl-Prolyl Isomerases in Human Pathologies.

Tuccinardi T, Rizzolio F. Tuccinardi T, et al. Front Pharmacol. 2019 Jul 11;10:794. doi: 10.3389/fphar.2019.00794. eCollection 2019. Front Pharmacol. 2019. PMID: 31354501 Free PMC article. No abstract available.

5

Application of a FLAP-consensus docking mixed strategy for the identification of new fatty acid amide hydrolase inhibitors.

Poli G, Giuntini N, Martinelli A, Tuccinardi T. Poli G, et al. Among authors: tuccinardi t. J Chem Inf Model. 2015 Mar 23;55(3):667-75. doi: 10.1021/ci5006806. Epub 2015 Mar 12. J Chem Inf Model. 2015. PMID: 25746133

6

What is the current value of MM/PBSA and MM/GBSA methods in drug discovery?

Tuccinardi T. Tuccinardi T. Expert Opin Drug Discov. 2021 Nov;16(11):1233-1237. doi: 10.1080/17460441.2021.1942836. Epub 2021 Jun 24. Expert Opin Drug Discov. 2021. PMID: 34165011 No abstract available.

7

CDK inhibitors: from the bench to clinical trials.

Rizzolio F, Tuccinardi T, Caligiuri I, Lucchetti C, Giordano A. Rizzolio F, et al. Among authors: tuccinardi t. Curr Drug Targets. 2010 Mar;11(3):279-90. doi: 10.2174/138945010790711978. Curr Drug Targets. 2010. PMID: 20210753 Review.

8

Adenosine receptor ligands in clinical trials.

Rizzolio F, La Montagna R, Tuccinardi T, Russo G, Caputi M, Giordano A. Rizzolio F, et al. Among authors: tuccinardi t. Curr Top Med Chem. 2010;10(10):1036-45. doi: 10.2174/156802610791293154. Curr Top Med Chem. 2010. PMID: 20370654 Review.

9

Cyclic Ketoximes as Estrogen Receptor β Selective Agonists.

Granchi C, Lapillo M, Spena CR, Rizzolio F, Tuccinardi T, Martin TA, Carlson KE, Katzenellenbogen JA, Minutolo F. Granchi C, et al. Among authors: tuccinardi t. ChemMedChem. 2016 Aug 19;11(16):1752-61. doi: 10.1002/cmdc.201600140. Epub 2016 May 2. ChemMedChem. 2016. PMID: 27135651 Free PMC article.

10

Bottom-up synthesis of carbon nanoparticles with higher doxorubicin efficacy.

Bayda S, Hadla M, Palazzolo S, Kumar V, Caligiuri I, Ambrosi E, Pontoglio E, Agostini M, Tuccinardi T, Benedetti A, Riello P, Canzonieri V, Corona G, Toffoli G, Rizzolio F. Bayda S, et al. Among authors: tuccinardi t. J Control Release. 2017 Feb 28;248:144-152. doi: 10.1016/j.jconrel.2017.01.022. Epub 2017 Jan 14. J Control Release. 2017. PMID: 28093297 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

216 results

Search Page